Connect with us
96% of the biotech companies are SMEs or micro-SMEs, contributing minimally to the Spanish biotech sector revenues. Large firms, though only 4.1%, account for 37.9% of...
In 2023, Spanish biotech companies secured 228 million euros in private financing, a 37% increase from 2022. This was announced at the AseBio Investor Day, organized...
In 2022, spending on biotechnology Research and Development (R&D) increased by 13% to reach 2.56 billion euros. Company expenditure grew by 17.8%, accounting for 47.7% of...
There are many companies in the biomedical sector that, being in the investment or expansion phase, have negative or reduced quotas. Given this particularity, what monetization...
Spanish biotech companies maintain their leading position in the industrial sector in science with the highest percentage of researchers. The research workplaces Spain in the ninth position...
Grifols, which specializes in the production of plasma derivatives, achieved a profit of $317.2 million (€266.8 million) in the first half of 2021, which translates into...
Spanish investment funds and venture capital managers have avoided the impact of the pandemic and have continued to invest in the health sector. Spanish biotech companies...